ASCO 2018 bladder and kidney cancer highlights
A variety of highlighly anticipated urological oncology research with great potential was shown at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL. Here, Neal Shore, M...
Author: VJOncology
Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts
ASCO 2018 bladder and kidney cancer highlights
A variety of highlighly anticipated urological oncology research with great potential was shown at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL. Here, Neal Shore, M...
Author: VJHemOnc
Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Does Nab-Paclitaxel Improve Outcomes Compared to Paclitaxel in Second Line Treatment of Transitional Cell Carcinoma of the Bladder (or other cancers)? Highlights from ASCO 2018 (BMIC-048)
Dr. Daniel Goldstein reviews trial results comparing nab-paclitaxel to standard paclitaxel in second line treatment of bladder cancer, comparing these results to those in breast cancer and raising que...
Author: BeaconMedIC
Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Could Immunotherapy Replace Neoadjuvant Chemo for Muscle-Invasive Transitional Cell Carcinoma? Highlights from ASCO 2018 (BMIC-047)
Dr. Daniel Goldstein reviews highlights in bladder cancer from ASCO 2018, including important studies evaluating the efficacy of neoadjuvant immunotherapy instead of chemotherapy for muscle-invasive t...
Author: BeaconMedIC
Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Molecular markers in high-risk muscle-invasive bladder cancer
Jeanny B. Aragon-Ching, MD, FACP, explains reliable molecular markers that can help identify high-risk muscle-invasive bladder cancer patients who should receive neoadjuvant therapy.
Author: obr
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
FGFR inhibitors in metastatic bladder cancer
Gary D. Steinberg, MD, explains whether FGFR inhibitors in metastatic bladder cancer have the potential to be practice changing at ASCO 2018.
Author: obr
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
New guidelines in treatment of metastatic bladder cancer
Jeanny B. Aragon-Ching, MD, FACP, discusses how new guidelines have changed the treatment of advanced metastatic bladder cancer at ASCO 2018.
Author: obr
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Bladder Cancer is No Longer Just One Disease | Different Biologies & Response in Benefit
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Bladder Cancer is No Longer Just One Disease | Different Biologies & Response in Benefit at ASCO 2018<br />
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Looking towards the future: what is in store for the treatment of bladder cancer?
The future is looking bright for bladder cancer, with many clinical studies of new therapeutic options underway. Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conferenc...
Author: VJOncology
Added: 04/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 9, 2018 Category: Cancer & Oncology Source Type: podcasts
How can we continue the success of checkpoint inhibitors for bladder cancer treatment?
The past several years have been extremely exciting in the field of bladder cancer, with checkpoint inhibitors emerging as efficacious therapies for otherwise refractory cancer. In this interview, And...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
A golden age for bladder cancer publications
The 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, hosted an exciting Best of Journals session, highlighting key research over the past year. Speaking from the meeting, Andrea Apol...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Unmet needs in bladder cancer in the immunotherapy era
Despite there now being a variety of promising immunotherapies for bladder cancer, a large proportion of patients dont respond to these. Speaking from the 2018 Genitourinary Cancers Symposium, held i...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
POUT trial: could there be a new standard of care for upper tract urothelial carcinoma?
There was exciting news in the field of bladder cancer treatment at the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA. Speaking from the meeting, Alison Birtle, MRCP, FRCR, MD, of La...
Author: VJOncology
Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts
POUT trial: a new standard of care for upper tract urothelial carcinoma
There was exciting news in the field of bladder cancer treatment at the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA. Speaking from the meeting, Alison Birtle, MRCP, FRCR, MD, of La...
Author: VJOncology
Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment options for patients with bladder cancer, is bladder removal always necessary?
Bladder preservation remains a viable option for certain patients with bladder cancer; with previous studies showing that patients up to the age of 84 can be safely treated with bladder preserving pro...
Author: VJOncology
Added: 03/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 14, 2018 Category: Cancer & Oncology Source Type: podcasts
